Setting Footprint in Europe: VasoDynamics setting up VDL Pharma B.V. in Leiden Bioscience Park, the Netherlands
10th -Aug- 2025
VasoDynamics Ltd, the pharmaceutical company developing patient-friendly cost-effective therapies for the prevention/reduction of debilitating side-effects induced by anti-cancer treatments, is pleased to announce that it has established a sub-company, VDL Pharma B.V. in the Leiden Bioscience Park, the Netherlands.
Dr Ningfeng Fiona Li, CEO of VasoDynamics, said:
"We are pleased to have completed the registration of VDL Pharma B.V. at the leading life science cluster, Leiden Bioscience Park, with tremendous support from the Netherlands Foreign Investment Agency and the Innovation Quarter. This represents an important step for VasoDynamics to (re)gain access to the wealth of drug development resources and regulatory support in Europe, and further pave our path to European collaborators, partners and markets."
For enquiries, please contact:
Dr Ningfeng Fiona Li, CEO
fiona.li@vasodynamics.co.uk
Notes to Editors:
About VasoDynamics
VasoDynamics is a pharmaceutical development company based in Stevenage-London, UK. It is a clinical stage biopharma company with experienced and culture-diversified executives who have shared vision to improve the standard of cancer care globally. Recognising the mounting cost pressures facing healthcare payers all over the world, the company is developing a number of cost-effective medicines, all of which target the prevention of debilitating and often dose-limiting complications of cancer therapy, such as chemotherapy and radiotherapy induced mucositis, dermatitis, and hair-loss. We take great pride in our culture of scientific and development rigour, and our programmes are based on scientific finding and innovations from world-leading research bodies. The company's proprietary technology platform utilises the different dynamics of normal and cancerous vasculatures developing a serials of pipeline products for various types of cancer patient cohorts, hence to achieve the most effective and patient friendly protections to prevent severe side-effects during various types of cancer treatments.